Infect Chemother.  2013 Dec;45(4):462-464. 10.3947/ic.2013.45.4.462.

Analysis of Host Factor related to Patient's Mortality due to Viridans Streptococcal Bacteremia

• Song SK
• Hwang JH
• Chung KM
• Lee CS

• KMID: 2170453
• DOI: http://doi.org/10.3947/ic.2013.45.4.462

Abstract

No abstract available.

MeSH Terms

Bacteremia*
Mortality*

Reference

1. Suh YS, Kim MK, Huh JH, Cho OH, Kim JR, Kim S, Bae IG. Factors associated with infective endocarditis and predictors of 3-month mortality of patients with viridans streptococcal bacteremia. Infect Chemother. 2012; 44:419–425. Bochud PY, Calandra T, Francioli P. Bacteremia due to viridians streptococci in neutropenic patients : a review. Am J Med 1994;97:256-64.

2. Singh KP, Morris A, Lang SD, MacCulloch DM, Bremner DA. Clinically significant Streptococcus anginosus (Streptococcus melleri) infections: a review of 186 cases. N Z Med J. 1988; 101:813–816.

3. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT. American Heart Association. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA. 1995; 274:1706–1713.

4. Tunkel AR, Sepkowitz KA. Infections caused by viridians streptococci in patients with neutropenia. Clin Infect Dis. 2002; 34:1524–1529.

5. Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents. 2000; 14:129–135.